Nau Jeffrey 4
4 · Oyster Point Pharma, Inc. · Filed Jul 8, 2022
Insider Transaction Report
Form 4
Nau Jeffrey
DirectorPresident and CEO
Transactions
- Award
Performance Stock Units
2022-07-06+350,000→ 350,000 totalExp: 2032-07-05→ Common Stock (350,000 underlying)
Footnotes (2)
- [F1]Represents a grant of performance stock units (the "PSUs"). Each PSU represents a contingent right to receive one share of Common Stock of the Issuer.
- [F2]The PSUs will vest as to (i) 50% on July 6, 2023; and (ii) 50% at such time, if any, beginning on July 6, 2023 and ending on July 6, 2024, the 30 day volume-weighted average stock price reaches $6.00 per share (the "VWAP Vesting Period"), subject to the Reporting Person's continuous service to the Issuer through each such date. For clarity, the applicable thirty (30) consecutive day period must occur entirely during the VWAP Vesting Period and the thirty (30) day volume-weighted average stock price will be measured during any thirty (30) consecutive trading days during such VWAP Vesting Period.